180 Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $382K | Sell |
761
-65
| -8% | -$31.2K | 0.04% | 338 |
|
|
2026
Q1 | $406K | Sell |
826
-2
| -0.2% | -$1.08K | 0.05% | 307 |
|
|
2025
Q4 | $480K | Sell |
828
-57
| -6% | -$32.2K | 0.05% | 273 |
|
|
2025
Q3 | $429K | Sell |
885
-281
| -24% | -$131K | 0.05% | 285 |
|
|
2025
Q2 | $473K | Buy |
1,166
+13
| +1% | +$5.43K | 0.07% | 251 |
|
|
2025
Q1 | $574K | Sell |
1,153
-31
| -3% | -$16.8K | 0.09% | 208 |
|
|
2024
Q4 | $616K | Buy |
1,184
+17
| +1% | +$9.35K | 0.1% | 195 |
|
|
2024
Q3 | $722K | Sell |
1,167
-9
| -0.8% | -$5.33K | 0.11% | 174 |
|
|
2024
Q2 | $638K | Buy |
1,176
+10
| +0.9% | +$5.73K | 0.1% | 181 |
|
|
2024
Q1 | $678K | Sell |
1,166
-18
| -2% | -$10.1K | 0.12% | 165 |
|
|
2023
Q4 | $644K | Sell |
1,184
-2,945
| -71% | -$1.43M | 0.13% | 164 |
|
|
2023
Q3 | $2.09M | Buy |
4,129
+74
| +2% | +$39.4K | 0.47% | 59 |
|
|
2023
Q2 | $2.1M | Sell |
4,055
-93
| -2% | -$50.2K | 0.46% | 59 |
|
|
2023
Q1 | $2.39M | Sell |
4,148
-50
| -1% | -$28.2K | 0.56% | 48 |
|
|
2022
Q4 | $2.42M | Buy |
4,198
+3
| +0.1% | +$1.59K | 0.57% | 49 |
|
|
2022
Q3 | $2.13M | Sell |
4,195
-66
| -2% | -$36.9K | 0.59% | 47 |
|
|
2022
Q2 | $2.34M | Sell |
4,261
-327
| -7% | -$180K | 0.6% | 42 |
|
|
2022
Q1 | $2.63M | Buy |
4,588
+339
| +8% | +$195K | 0.57% | 46 |
|
|
2021
Q4 | $2.47M | Buy |
4,249
+15
| +0.4% | +$9.37K | 0.55% | 45 |
|
|
2021
Q3 | $2.47M | Buy |
4,234
+19
| +0.5% | +$10.4K | 0.54% | 43 |
|
|
2021
Q2 | $2.28M | Sell |
4,215
-67
| -2% | -$31.6K | 0.52% | 45 |
|
|
2021
Q1 | $1.98M | Sell |
4,282
-664
| -13% | -$317K | 0.49% | 57 |
|
|
2020
Q4 | $2.51M | Sell |
4,946
-142
| -3% | -$66.6K | 0.72% | 27 |
|
|
2020
Q3 | $2.37M | Sell |
5,088
-62
| -1% | -$25.6K | 0.89% | 23 |
|
|
2020
Q2 | $2.04M | Sell |
5,150
-15
| -0.3% | -$5.03K | 0.81% | 26 |
|
|
2020
Q1 | $1.49M | Buy |
5,165
+190
| +4% | +$59.9K | 0.77% | 29 |
|
|
2019
Q4 | $1.67M | Buy |
4,975
+303
| +6% | +$91.9K | 0.67% | 30 |
|
|
2019
Q3 | $1.32M | Buy |
4,672
+320
| +7% | +$91.6K | 0.59% | 43 |
|
|
2019
Q2 | $1.21M | Sell |
4,352
-119
| -3% | -$32.8K | 0.54% | 48 |
|
|
2019
Q1 | $1.22M | Sell |
4,471
-178
| -4% | -$44.3K | 0.55% | 47 |
|
|
2018
Q4 | $1.14M | Hold |
4,649
| – | – | 0.53% | 48 |
|
|
2018
Q3 | $1.14M | Sell |
4,649
-407
| -8% | -$93.6K | 0.52% | 49 |
|
|
2018
Q2 | $1.05M | Buy |
5,056
+608
| +14% | +$129K | 0.52% | 54 |
|
|
2018
Q1 | $922K | Buy |
4,448
+329
| +8% | +$69.1K | 0.48% | 68 |
|
|
2017
Q4 | $782K | Buy |
+4,119
| New | +$789K | 0.4% | 79 |
|
Other funds holding TMO
180 Wealth Advisors's TMO Position: Q2 2026 in Review
180 Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 7.9% in Q2 2026, selling an estimated $31.2K and leaving 761 shares worth $382K. The position accounts for 0.04% of the portfolio, ranked #338.
180 Wealth Advisors first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.63M in Q1 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- 180 Wealth Advisors held 761 shares of Thermo Fisher Scientific worth $382K as of Q2 2026.
- 180 Wealth Advisors sold 65 Thermo Fisher Scientific shares in Q2 2026, an estimated $31.2K.
- Thermo Fisher Scientific made up 0.04% of 180 Wealth Advisors's portfolio in Q2 2026, its #338 holding.
- 180 Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- 180 Wealth Advisors's Thermo Fisher Scientific position peaked at $2.63M in Q1 2022.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.